Search

Dual response polyurethane nanocapsules consisting of a hydrophilic core are synthesized via interfacial polyaddition of the diisocyanate monomers and different diols (VA‐060 and glycols) in inverse miniemulsion process. The presence of the water‐soluble NIR dye in the core and azo‐bonds in the polymer shell allows the selective release of encapsulated material triggered by temperature or NIR light. The capsules are characterized by transmission electron microscopy (TEM) and dynamic light scattering (DLS). The capsule degradation under external stimuli, like temperature and NIR light, is confirmed microscopically by TEM. Macroscopic evidence of the capsule cleavage was achieved by the incorporation of the chemical into the capsule core, and subsequent treatment of the capsules with NIR laser in the presence of the suitable reagent outside the capsules. A color‐forming chemical reaction occurred after the shell opening. The reactions were easily detected by visual observation of a color change and by UV–Vis spectroscopy. [ABSTRACT FROM AUTHOR]

ABSTRACT The present study aimed at investigating and modelling the release behaviour of encapsulated d‐limonene from electrosprayed Alyssum homolocarpum seed gum (AHSG) nanoparticles. For this purpose, release profiles of d‐limonene from 10% or 20% loaded nanocapsules were obtained in deionised water and simulated mouth conditions by a spectrophotometric method. The experimental results showed that complete release takes ranging between 7 and 15 min, depending on the d‐limonene loading and type of release medium. A gradual increase in the flavour release rate over time without initial burst revealed there are several phenomena involved in the release process due to the hydrophilic nature of AHSG nanocapsules. Based on these findings, a mechanistic approach modelled flavour diffusion as a transport process of combined matrix swelling and erosion mechanisms. The model parameters were obtained via best fitting procedure applying simulated annealing (SA) algorithm. The good correlation between the predicted and experimental results of d‐limonene release confirmed validation of the developed model. The simulation results showed that although matrix erosion contributes more than diffusion process in d‐limonene release from AHSG nanocapsules, the model describing the release mechanism as only governed by the erosion is not able to provide accurate predictions of flavour release as compared to the coupled model. [ABSTRACT FROM AUTHOR]

In this study, nanocapsules encapsulating avobenzone (AVB) compounded with isooctyl p‐dimethylaminobenzoate (OD‐PABA) were prepared via miniemulsion polymerization using methyl methacrylate (MMA) as the monomer, ethylene glycol dimethacrylate (EGDMA) as the cross‐linker, and poly(styrene‐co‐methacrylic acid) (P(St‐co‐MAA)) as the polymeric emulsifier. When a solid ultraviolet radiation A (UVA) filter, AVB, was encapsulated in nanocapsules (A‐UVNCs), the encapsulation and loading rates were 67.6% and 9.7%, respectively. When a liquid ultraviolet radiation B (UVB) filter, OD‐PABA, was combined with AVB, the encapsulation and loading rates of the nanocapsules (A/O‐UVNCs) of AVB and OD‐PABA increased to 90.0% and 15.6%, respectively, and 71.5% and 14.0%, respectively. The A/O‐UVNCs realized broad‐spectrum ultraviolet (UV) protection with an SPF value of 46.3. The A/O‐UVNCs have raspberry‐like nanostructures. These submicron particles can scatter and reflect a portion of the UV radiation and synergistically enhance UV protection. After exposure to simulated sunlight for four hours, the UVAPF of a sunscreen containing A‐UVNCs or A/O‐UVNCs decreased to a smaller extent than that of the sunscreen containing free AVB. Cell toxicity experiments showed that the cell viability of A‐UVNCs and A/O‐UVNCs was 85.9% and 83.0%, respectively. Therefore, UVNCs not only enhance UV protection but also improve photostability and safety. [ABSTRACT FROM AUTHOR]

ABSTRACT This study aimed to evaluate the ability of Persian gum to encapsulate curcumin and enhance its stability in dairy products. Given the increasing interest in functional foods, this study investigated the incorporation of nanocapsules containing curcumin (CLN) into functional stirred yogurt (CLN‐Y). CLN was prepared with Persian gum (PG) at different levels and included in the yogurt formula (CLN‐Y1%, CLN‐Y2%, and CLN‐Y3%). The physicochemical properties, rheological characteristics, antioxidant activity (AA), survival of starter bacteria, and sensory properties of the yogurt were evaluated over a 21‐day storage period at 4°C. The results showed that CLN significantly improved AA (reduction of 7.31% in the control vs. 1.85% in CLN‐Y3%), viscosity, hardness, and water holding capacity (reduction of 2.27% in control vs. 1.14% in CLN‐Y3%), while reducing syneresis (an increase of 10.87% in control vs. 3.16% in CLN‐Y3%) during storage (p < 0.05). CLN concentration directly affected AA. Although CLN‐Y exhibited a yellowish color and lower light intensity than the control, the samples were well accepted during storage. Increasing CLN levels led to decreased taste, color, and overall acceptance scores, and a 3% concentration is recommended for yogurt formulation due to its potential to improve yogurt quality, provide antioxidant benefits, maintain probiotic viability, and achieve high consumer acceptance during storage. [ABSTRACT FROM AUTHOR]

This study highlights the significance of polymers in the progress of nanoparticles across various areas. The molecules of polymers are highly regarded for their ability to adapt and self‐assemble, making them essential components in the creation of nanomaterials. The variety of polymers include natural polymers such as chitosan, synthetic polymers like polyethylene, and biodegradable polymers like poly(lactic‐co‐glycolic acid) (PLGA). These kinds of polymers possess distinct advantages such as high strength, environmental sustainability, and biocompatibility. Incorporation of nanoscale fillers into polymer matrices, which enhances the mechanical, thermal, and electrical properties of materials, is crucial for the development of nanocomposites. Illustration instances encompass carbon nanotube‐polymer composites and polymer clay hybrids, which find application in the construction, automotive, and aerospace sectors. Composites can employ many synthetic methods to generate nanostructures. Nanofibers have utility in tissue engineering, whereas polymer nanoparticles function as carriers for medical delivery. Also, polymers enhance nanomaterials by modifying their surfaces, a crucial factor for their application in membrane technology, catalysis, and sensing. A collaborative synergy between polymers and nanoparticles fosters a wide range of applications, showcasing the versatility and potential of polymers in altering the characteristics of nanomaterials. The resulting partnership continues to generate pioneering breakthroughs that address complex challenges and unveil unprecedented prospects in the domains of science, technology, and business. [ABSTRACT FROM AUTHOR]

Curcumin (Cur), the primary curcuminoid found in Curcuma longa L., has garnered significant attention for its potential anti-inflammatory and antibacterial properties. However, its hydrophobic nature significantly limits its bioavailability. Additionally, adipose-derived stem cells (ADSCs) possess immunomodulatory properties, making them useful for treating inflammatory and autoimmune conditions. This study aims to verify the efficacy of poly(ε-caprolactone) nanocapsules (NCs) in improving Cur's bioavailability, antibacterial, and immunomodulatory activities. The Cur-loaded nanocapsules (Cur-NCs) were characterized for their physicochemical properties (particle size, polydispersity index, Zeta potential, and encapsulation efficiency) and stability over time. A digestion test simulated the behavior of Cur-NCs in the gastrointestinal tract. Micellar phase analyses evaluated the Cur-NCs' bioaccessibility. The antibacterial activity of free Cur, NCs, and Cur-NCs against various Gram-positive and Gram-negative strains was determined using the microdilution method. ADSC viability, treated with Cur-NCs and Cur-NCs in the presence or absence of lipopolysaccharide, was analyzed using the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide assay. Additionally, ADSC survival was assessed through the Muse apoptotic assay. The expression of both pro-inflammatory (interleukin-1β and tumor necrosis factor-α) and anti-inflammatory (IL-10 and transforming growth factor-β) cytokines on ADSCs was evaluated by real-time polymerase chain reaction. The results demonstrated high stability post-gastric digestion of Cur-NCs and elevated bioaccessibility of Cur post-intestinal digestion. Moreover, Cur-NCs exhibited antibacterial activity against Escherichia coli without affecting Lactobacillus growth. No significant changes in the viability and survival of ADSCs were observed under the experimental conditions. Finally, Cur-NCs modulated the expression of both pro- and anti-inflammatory cytokines in ADSCs exposed to inflammatory stimuli. Collectively, these findings highlight the potential of Cur-NCs to enhance Cur's bioavailability and therapeutic efficacy, particularly in cell-based treatments for inflammatory diseases and intestinal dysbiosis. [ABSTRACT FROM AUTHOR]

Osteoarthritis (OA) is a prevalent joint disease characterized by cartilage degeneration and subchondral bone homeostasis imbalance. Effective topical OA therapy is challenging, as therapeutic drugs often suffer from insufficient penetration and rapid clearance. We develop miniature polydopamine (PDA) nanocapsules (sub-60 nm), which are conjugated with collagen-binding polypeptide (CBP) and loaded with an anabolic drug (i.e., parathyroid hormone 1–34, PTH 1–34) for efficient OA treatment. Such multifunctional polymeric nanocapsules, denoted as PDA@CBP-PTH, possess deformability when interacting with the dense collagen fiber networks, enabling the efficient penetration into 1 mm cartilage in 4 h and prolonged retention within the joints up to 28 days. Moreover, PDA@CBP-PTH nanocapsules exhibit excellent reactive oxygen species scavenging property in chondrocytes and enhance the anabolism in subchondral bone. The nanosystem, as dual-mode treatment for OA, demonstrates rapid penetration, long-lasting effects, and combinational therapeutic impact, paving the way for reversing the progression of OA for joint health care. [Display omitted] • Miniature, uniform, and deformable PDA nanocapsule system was developed. • The nanocapsules penetrated 1 mm of cartilage within 4 h. • The nanocapsules exhibited prolonged retention in knee joints for up to 28 days. • Dual therapeutic effects included enhanced antioxidant and bone anabolism. [ABSTRACT FROM AUTHOR]

Liquid-core nanocapsules (NCs) coated with amphiphilic hyaluronic acid (AmHA) have been proposed for the preparation of drug and food formulations. Herein, we focused on the use of ultrasound techniques to (i) optimize the polysaccharide chain length with respect to the properties of NCs stabilized with AmHAs and (ii) form oil-core nanocapsules with a coating composed of AmHAs. The results indicate that sonication is a convenient and effective method that allows for a controlled reduction in HA molecular weight. The initial (H-HA) and degraded (L-HA) polysaccharides were then reacted with dodecylamine to obtain hydrophobic HA derivatives (HA-C12s). Then, NCs were prepared based on HA-C12s using ultrasound-assisted emulsification of glyceryl triacetate oil. The nanocapsules coated with L-HA-C12 showed greater stability compared to the longer-chain polysaccharide. Molecular dynamics (MD) simulations revealed that HA-C12 readily adsorbs at the water–oil interphase, adopting a more compact conformation compared to that in the aqueous phase. The dodecyl groups are immersed in the oil droplet, while the main polysaccharide chain remaining in the aqueous phase forms hydrogen bonds or water bridges with the polar part of the triglycerides, thus increasing the stability of the NC. Our research underscores the usefulness of ultrasound technology in preparing suitable formulations of bioactive substances. [ABSTRACT FROM AUTHOR]

Nanocapsules enable multicomponent encapsulation of therapeutic cargoes with high encapsulation content and efficiency, which is vital for cancer immunotherapy. In the past, chemical crosslinking is used to synthesize nanocapsules, which can impede the regulatory approval process. Therefore, a new class of protein nanocapsules is developed by eliminating the need for chemical crosslinking by utilizing protein denaturation through a process that is referred to as "baking at the droplet interface". Such protein nanocapsules with antigens incorporated in the shell and a combination of encapsulated drugs showed an enhancement in the immune response of cells. [ABSTRACT FROM AUTHOR]

Theranostics is a growing field that matches diagnostics and therapeutics. In this approach, drugs and techniques are uniquely coupled to diagnose and treat medical conditions synergically or sequentially. By integrating diagnostic and treatment functions in a single platform, the aim of theranostics is to improve precision medicine by tailoring treatments based on real-time information. In this context, lipid-based nanocarriers have attracted great scientific attention due to their biodegradability, biocompatibility, and targeting capabilities. The present review highlights the latest research advances in the field of lipid-based nanocarriers for cancer theranostics, exploring several ways of improving in vivo performance and addressing associated challenges. These nanocarriers have significant potential to create new perspectives in the field of nanomedicine and offer promise for a significant step towards more personalized and precise medicine, reducing side effects and improving clinical outcomes for patients. This review also presents the actual barriers to and the possible challenges in the use of nanoparticles in the theranostic field, such as regulatory hurdles, high costs, and technological integration. Addressing these issues through a multidisciplinary and collaborative approach among institutions could be essential for advancing lipid nanocarriers in the theranostic field. Such collaborations can leverage diverse expertise and resources, fostering innovation and overcoming the complex challenges associated with clinical translation. This approach will be crucial for realizing the full potential of lipid-based nanocarriers in precision medicine. [ABSTRACT FROM AUTHOR]

The assessment of ricinoleic acid (RA) incorporated into polymeric nanoparticles is a challenge that has not yet been explored. This bioactive compound, the main component of castor oil, has attracted attention in the pharmaceutical field for its valuable anti-inflammatory, antifungal, and antimicrobial properties. This work aims to develop a new and simple analytical method using high-performance liquid chromatography with diode-array detection (HPLC-DAD) for the identification and quantification of ricinoleic acid, with potential applicability in several other complex systems. The method was validated through analytical parameters, such as linearity, limit of detection and quantification, accuracy, precision, selectivity, and robustness. The physicochemical properties of the nanocapsules were characterized by dynamic light scattering (DLS) to determine their hydrodynamic mean diameter, polydispersity index (PDI), and zeta potential (ZP), via transmission electron microscopy (TEM) and quantifying the encapsulation efficiency. The proposed analytical method utilized a mobile phase consisting of a 65:35 ratio of acetonitrile to water, acidified with 1.5% phosphoric acid. It successfully depicted a symmetric peak of ricinoleic acid (retention time of 7.5 min) for both the standard and the RA present in the polymeric nanoparticles, enabling the quantification of the drug loaded into the nanocapsules. The nanocapsules containing ricinoleic acid (RA) exhibited an approximate size ranging from 309 nm to 441 nm, a PDI lower than 0.2, ζ values of approximately −30 mV, and high encapsulation efficiency (~99%). Overall, the developed HPLC-DAD procedure provides adequate confidence for the identification and quantification of ricinoleic acid in PLGA nanocapsules and other complex matrices. [ABSTRACT FROM AUTHOR]

Ferroptosis-mediated multimodal therapy has emerged as a promising strategy for tumor elimination, with lipid peroxide (LPO) playing a pivotal role. However, the therapeutic efficiency is limited due to insufficient intracellular levels of free fatty acids (FFA), which severely hinder the production of LPO. To address this limitation, we proposed a lipophagy strategy aimed at degrading lipid droplets (LDs) to release FFA, serving as the essential "fuel" for LPO production. In this study, the lipophagy inducer epigallocatechin gallate (EGCG) was self-assembled with reactive oxygen species (ROS)-producer phenethyl isothiocyanate (PEITC) mediated by Fe2+ to form EFP nanocapsules, which were further integrated into microneedle patches to form a "all-in-one" EFP@MNs. The metal-polyphenol network structure of EFP endow it with photothermal therapy capacity. Upon insertion into tumors, the released EFP nanocapsules were demonstrated to induce lipophagy through metabolic disturbance, thereby promoting LPO production and facilitating ferroptosis. When combined with photothermal therapy, this approach significantly remolded the tumor immune microenvironment by driving tumor-associated macrophages toward M1 phenotype and enhancing dendritic cell maturation. Encouragingly, in conjunction with αPD-L1 treatment, the proposed EFP@MNs exhibited remarkable efficacy in tumor ablation. Our study presents a versatile framework for utilizing microneedle patches to power ferroptosis-mediated multimodal therapy. [Display omitted] [ABSTRACT FROM AUTHOR]

Objectives: Furosemide (FSM), a potent loop diuretic, is used to treat edema due to hypertension, congestive heart failure, and liver and renal failures. FSM applications are limited by its low bioavailability. Our aim is to use different nanoencapsulation strategies to control the release of FSM and enhance its pharmacokinetic properties. Methods: Two types of FSM-loaded nanocapsules, namely FSM-loaded lipid nanocapsules (LNCs) and polymeric nanocapsules (PNCs), were developed, physicochemically characterized, and subjected to pharmacokinetic and pharmacodynamic studies. Lipid nanocapsules were prepared by the simple phase inversion method using LabrafacTM lipid, while the polymeric nanocapsules were prepared by nanoprecipitation method using polycaprolactone polymer. Results: Transmission electron microscopy ascertains spherical structures, corroborating the nanometric diameter of both types of nanocapsules. The particle size of the optimized FSM-loaded LNCs and FSM-loaded PNCs was 32.19 ± 0.72 nm and 230.7 ± 5.13 nm, respectively. The percent entrapment efficiency was 63.56 ± 1.40% of FSM for the optimized PNCs. The in vitro release study indicated prolonged drug release compared to drug solutions. The two loaded nanocapsules systems succeeded in enhancing the pharmacokinetic parameters in comparison to the marketed FSM solution with superior diuretic activity (p < 0.05). The results of the stability study and the terminal sterilization by autoclave indicated the superiority of LNCs over PNCs in maintaining the physical parameters under storage conditions and the drastic conditions of sterilization. Conclusions: LNCs and PNCs are considered promising nanosysems for improving the diuretic effect of FSM. [ABSTRACT FROM AUTHOR]

Cystic echinococcosis still remains a serious health and economic problem worldwide. The etiologic agent is Echinococcus granulosus sensu lato, giving origin to a fluid-filled cystic lesion. Therapy faces several challenges. Nanodrugs have shown promise as chemotherapeutics against hydatid cysts. The present study evaluated a highly safe lipid nano-polymeric capsule for its superior efficacy and ability to overcome drug resistance. Nanocapsule drugs were formulated into six groups: Albendazole, mebendazole, praziquantel, albendazole + mebendazole, albendazole + praziquantel, and praziquantel + mebendazole. The protoscolicidal effects of these six groups were assessed at 10, 60, and 120 min in three concentrations (1, 0.5, and 0.25 mg/mL). Drug formulations were evaluated via zeta potential, droplet size, solubility, particle size analyzer (PSA), and scanning electron microscopy. According to the PSA results, the mean size of the albendazole nanocapsules was 193.01 nm, mebendazole was 170.40 nm, and praziquantel was 180.44 nm. Albendazole + mebendazole showed the greatest protoscolicidal activity at a concentration of 1 mg/mL after 120 min. In contrast, each drug's 0.25 mg/mL single-dose times showed the least protoscolicidal activity after 120 min. With the right application of nanotechnology, it is possible to produce safe and effective drugs, such as the polymeric combination of albendazole and mebendazole, which has promising implications. [ABSTRACT FROM AUTHOR]

The hydrophobicity governs the nanoarchitecture formation of oil-loaded quaternary ammonium palmitoyl glycol chitosan (GCPQ)-nanocapsules. Mathematical models were applied to obtain a predictive equation to produce different particle sizes which nanoarchitecture depended on DP, DQ, cHLB, and oil concentration. Thus, multiple – or single – oil cores with small particles stabilizing polymer shells could be observed depending on the composition. [Display omitted] Predicting the exact nature of the self-assembly of amphiphilic molecules into supramolecular structures is of utmost importance for a variety of applications, but this is a challenge for nanotechnology. The amphiphilic drug delivery polymer- N -palmitoyl- N -monomethyl- N,N -dimethyl -N,N,N -trimethyl-6-O-glycolchitosan (GCPQ) self-assembles in aqueous media to form nanoparticles. This work aimed to develop a systematic predictive mathematical model on the eventual nature of oil-loaded GCPQ-nanoparticles and to determine the main independent variables that affect their nanoarchitecture following self-assembly. GCPQ polymers were produced with varying degree of palmitoylation (DP, 5.7–23.8 mol%), degree of quaternization (DQ, 7.2–22.7 mol%), and molecular weight (MW, 11.2–44.2 kDa) and their critical hydrophilic-lipophilic balance (cHLB) optimized to produce oil-loaded nanocapsules. Non-linear mathematical models (Particle size (nm) = 466.05 − 5.64DP − 6.52DQ + 0.13DQ2 − 0.03 MW2 − 14.48cHLB + 0.48cHLB2) were derived to predict the nanoparticle sizes (R2 = 0.998, R2 adj = 0.995). Smaller nanoparticle sizes (148–157 nm) were obtained at high DP, DQ, and cHLB values, in which DP was the main independent variable responsible for nanoparticle size. Single or multiple-oil cores with small particles stabilizing polymer shells could be observed depending on the oil volume. Nanoparticle architectures, especially the nature of the oil-core(s), were driven by the DP, DQ, cHLB, and oil concentration. Here, we have developed a predictive model that may be applied to understand the nanoarchitecture of oil-loaded GCPQ-nanoparticles. [ABSTRACT FROM AUTHOR]

This study describes the comparison between the interaction of a series of peptide-functionalized chitosan-based nanocapsules and liposomes with two cell lines, i.e., mouse macrophages RAW 264.7 and human endothelial cells EA.hy926. Both types of nanocarriers are loaded with magnetic nanoparticles and designed for anti-inflammatory therapy. The choice of these magnetic nanostructures is argued based on their advantages in terms of size, morphology, chemical composition, and the multiple possibilities of modifying their surface. Moreover, active targeting might be ensured by using an external magnetic field. To explore the impact of chitosan-based nanocapsules and liposomes on cell cytophysiology, the cell viability, using the MTT assay, and cell morphology were investigated. The results revealed low to moderate cytotoxicity of free nanocapsules and significant cytotoxicity induced by chitosan-coated liposomes loaded with dexamethasone, confirming its release from the delivery system. Thus, after 48 h of treatment with nanocapsules, the viability of RAW 264.7 cells varied between 88.18% (OCNPM-1I, 3.125 µg/mL) and 76.37% (OCNPM-1, 25 µg/mL). In the same conditions, EA.hy926 cell viability was between 99.91% (OCNPM-3, 3.125 µg/mL) and 75.15% (OCNPM-3, 25 µg/mL) at the highest dose (25 µg/mL), the values being comparable for both cell lines. Referring to the cell reactivity after dexamethasone-loaded liposome application, the lowest viability of RAW 264.7 cells was 41.25% (CLDM5CP-1, 25 µg/mL) and 58.20% (CLDMM2CP-1 1.25 µg/mL) in the endothelial cell line, proving a selective character of action of nanocarriers. The cell morphology test, performed to support and confirm the results obtained by the MTT test, revealed a differentiated response for the two types of nano-carriers. As expected, an intense cytotoxic effect in the case of dexamethasone-loaded liposomes and a lack of cytotoxicity for drug-free nanocapsules were noticed. Therefore, our study demonstrated the biocompatible feature of the studied nanocarriers, which highlights them for future research as potential drug delivery systems for pharmacological applications, including anti-inflammatory therapy. [ABSTRACT FROM AUTHOR]

This study developed three microstructured chitosan nanocapsules with immobilized lipase to explore chitosan-lipase interactions at different pH levels. Chitosan undergoes complete protonation or deprotonation based on pH level. Three distinct pH levels were examined: 5.5, where chitosan is fully protonated; 6.5, where chitosan is partially protonated/deprotonated; and 7.5, where chitosan is fully deprotonated. The nanocapsules exhibited nanoscale dimensions and the microstructures showed porous morphology. Immobilized lipase showed improved temperature stability, compared to free enzyme, especially in lipase supports at pH 5.5 and 7.5 due to electrostatic and hydrophobic interactions. The interactions between chitosan and lipase influenced the microenvironment around the active site, resulting in an optimum pH of 8 for all supports. Immobilized lipase at pH 5.5 and 7.5 displayed the best reusability in the hydrolysis of p-nitrophenyl palmitate under reaction conditions of 37 °C and pH 8. During refrigeration storage, all immobilized lipases maintained total activity for 7 days, but lipase immobilized at pH 6.5 maintained more the activity after 28 days. Therefore, this study has developed promising immobilized lipase, standing out not only for industrial application concerning cost-effectiveness, but also for the innovation in investigating the influence of chitosan-lipase interactions during immobilization. [ABSTRACT FROM AUTHOR]

In this study, the effect of Thymus vulgaris essential oil (TVO) nanoemulsion (NE, 500 mg/L) in combination with ultrasound (ultrasound-NE) on the microbial and physiological quality of green bell pepper was investigated. The TVO-NE droplet size and zeta potential were 84.26 nm and − 0.77 mV, respectively. The minimum inhibitory concentrations of the TVO and TVO-NE against E. coli and S. aureus were about 0.07 and 7 g/L, respectively. The NE-ultrasound treatment exhibited the lowest peroxidase activity and respiration rate with no detrimental effect on texture, total phenolic content, antioxidant activity, pH, and TSS. Although the NE-ultrasound treatment showed the highest weight loss and electrolytic leakage, it exhibited the best visual color and appearance. The NE-ultrasound treatment descended the total viable/mold and yeast counts significantly compared to control. Results showed that treating the bell peppers with NE-ultrasound can result in bell peppers with good postharvest quality and extended shelf life. [ABSTRACT FROM AUTHOR]

The typical high-density zirconium carbide (ZrC) ceramic requires high temperature and high pressure, leading to high manufacturing cost for complex shapes. Herein, nano-sized carbon layer encapsulated ZrC particles were pressureless sintered to achieve near-net preparation of high-density and complex-shape ZrC ceramic. The results indicate that reaction between carbon layer and the ZrC x O y phase in ZrC was improved because the carbon layer shortened the oxygen diffusion pathway. The oxygen content decreased from 3.52 wt% to 0.82 wt% while the thickness of carbon layer decreased from 4.0 nm to 0.75 nm after sintering at 1950 °C for 1 h. Furthermore, the migration of oxygen from ZrC x O y phase to the carbon layer effectively facilitate the formation and growth of the sintering neck. The resulting ZrC ceramic exhibited a high relative density of 92.3 % and excellent mechanical properties. The Vickers hardness, indentation fracture toughness, micro hardness, elastic modulus, and flexural strength were 17.3 ± 0.7 GPa, 4.0 ± 0.5 MPa m1/2, 22.2 ± 2.4 GPa, 429.9 ± 20.7 GPa, and 324 ± 8 MPa, respectively. This work provides a novel perspective to fabricate near-net, high-density and complex-shape ZrC ceramic at lower temperature without pressure. [ABSTRACT FROM AUTHOR]

Background: Chloridazon belongs to the pyridazinone group of herbicides. Pyridazinone derivatives are known to have various pharmacological activities, including anti-cancer effects. Therefore, our study aimed to assess the cytotoxicity, apoptotic, anti-metastasis, and anti-angiogenesis effects of chloridazon-loaded alginate-chitosan nanocapsules on the 4T1 breast cancer cell line. Materials and Methods: The 4T1 cell line was cultured in RPMI 1640 media and treated with different concentrations of chloridazon-loaded alginate-chitosan nanocapsules. Cell viability was evaluated using the MTT assay, while cell vitality was assessed using the NR uptake assay. Apoptosis was induced and observed through acridine orange and propidium iodide staining. Furthermore, the expression levels of genes associated with metastasis (MMP-2 & MMP-9) and angiogenesis (VEGF-A) were analyzed using the RTPCR technique. Results: The chloridazon-loaded nanocapsules displayed increased cytotoxicity on the 4T1 cell line in a dose-dependent manner. As the treatment dose increased, both cell viability and vitality decreased. The IC50 of the nanoformulation was measured as 74 µg/ml based on the dose-response curve. Additionally, the nanoformulation was found to induce apoptosis and decrease the expression levels of genes related to metastasis (MMP-2 & MMP-9) and angiogenesis (VEGF-A). Notably, the doses of 100 µg/ml and 160 µg/ml of the nanoformulation exhibited the most significant effects. Conclusion: Our findings reveal that the chloridazon-loaded alginate -chitosan nanocapsules have the potential to exert cytotoxic effects on the 4T1 breast cancer cell line. [ABSTRACT FROM AUTHOR]

Extracts with antimicrobial and antioxidant properties are limited in their application in food products due to their inability to withstand harsh environmental conditions, such as high temperatures and oxygen exposure. Therefore, the present study investigated the nanoencapsulation of Teucrium polium L. extract using the freeze‐drying method to facilitate its application and protection against environmental factors. In this regard, an emulsion containing Teucrium polium L. extract at concentrations of 10%, 20%, and 30% and a mixture of maltodextrin/Persian gum in three ratios of 1:2, 1:1, and 2:1 as the coating wall were produced and then dried in a freeze dryer. In the following, the properties of emulsions and produced nanocapsules were studied. According to the results, emulsions with high amounts of Persian gum showed more stability, zeta potential, and viscosity. However, their particle size and polydisparity index were lower than those of other emulsions. As the extract concentration increased, there was a decrease in stability, zeta potential, and viscosity, accompanied by an increase in particle size and polydispersity index. Concurrently, elevated concentrations of maltodextrin, Persian gum, and extract resulted in higher humidity, density, encapsulation efficiency, and antioxidant activity of the capsules. The most optimal properties of emulsions and nanocapsules were achieved at the 10% concentration of Teucrium polium L. extract and the 1:1 ratio of maltodextrin/Persian gum mixture as the wall material. It is noteworthy that the release rate of phenolic compounds reached its maximum value (88%) after 60 days. [ABSTRACT FROM AUTHOR]

Telomerase activity is directly affected by the laminin receptor precursor (LRP) protein, a highly conserved nonintegrin transmembrane receptor, which has been shown to have therapeutic effects in ageing, and age‐related diseases. Recently, it has been found that overexpression of LRP‐FLAG, by plasmid transfection, leads to a significant increase in telomerase activity in cell culture models. This may indicate that upregulation of LRP can be used to treat various age‐related diseases. However, transfection is not a viable treatment strategy for patients. Therefore, we present a nanoencapsulated protein‐based drug synthesised using poly(lactic‐co‐glycolic acid) (PLGA) nanocapsules for delivery of the 37 kDa LRP protein therapeutic. PLGA nanocapsules were synthesised using the double emulsification‐solvent evaporation technique. Different purification methods, including filtration and centrifugation, were tested to ensure that the nanocapsules were within the optimal size range, and the BCA assay was used to determine encapsulation efficiency. The completed drug was tested in a HEK‐293 cell culture model, to investigate the effect on cell viability, LRP protein levels and telomerase activity. A significant increase in total LRP protein levels with a concomitant increase in cell viability and telomerase activity was observed. Due to the observed increase in telomerase activity, this approach could represent a safer alternative to plasmid transfection for the treatment of age‐related diseases. [ABSTRACT FROM AUTHOR]

The study presents a detailed investigation of the essential oil obtained by distilling the stems of Pelargonium roseum, also known as geranium oil, cultivated at the bio-farm of the Faculty of Pharmacy in Galați, Romania. Interest in this study was sparked by the potential applications of the oil in interdisciplinary fields such as pharmacy and dentistry, considering the diversity and varying concentrations of its phytoconstituents. The research is notable for focusing on the compositional analysis of oils obtained during the pandemic years 2020, 2021, and 2022, periods marked by the global SARS-CoV-2 health crisis. The chosen methodology for the detailed analysis of the oil components includes gas chromatography coupled with mass spectrometry, using the Adams protocol for precise identification and quantification. The mass spectra obtained were compared with those from the Wiley standard library, facilitating a rigorous evaluation of the chemical profiles. The main findings indicate a predominance of monoterpene alcohols - citronellol, geraniol, and linalool - present in free or esterified forms. Citronellol, in particular, stands out due to its high concentrations, conferring notable antibacterial and antifungal properties to the oil, superior to other volatile oils analyzed. This feature recommends it as a promising candidate for medical applications, especially in dentistry. Based on the results, the study proposes an in-depth exploration of the antibacterial efficacy of geranium oil, aiming at the development of new pharmaceutical preparations with controlled release. These preparations could enhance current treatments by offering efficient natural alternatives for preventing and combating bacterial and fungal infections in dental practice. Thus, the study emphasizes the importance of continuing research in this field, highlighting the valuable potential of essential oils in modern medical applications. [ABSTRACT FROM AUTHOR]

BACKGROUND: The encapsulation technique was applied to efficiently eliminate Congo red (CR) from aqueous solutions. During the ionotropic gelation between calcium (Ca2+) ions and alginate (AL), CR was effectively entrapped within the AL nanocapsules in a one‐step process. Suitable conditions for efficient CR removal via encapsulation were revealed by the systematic optimization of parameters including pH, time and stirring speed, etc. RESULTS: According to the experimental observations, the stirring rate and temperature were found to have an insignificant effect on the encapsulation of CR molecules. When the pH value of the medium was 3, the highest level of encapsulation efficiency was achieved in a period of 15 min. At a preliminary CR concentration of 2000 mg L−1 and pH 3, the encapsulation efficiency was calculated at ≈98.9%, with an encapsulation capacity of 2800 mg dye g−1 AL. The zeta potential values of AL and CR/AL nanocapsules were determined to be +7.05 eV and −14.9 eV, respectively, and the results showed that the particles tended to agglomerate. TEM micrographs also showed that the nanocapsules were nanosized and agglomerated. Soil and UV degradation studies showed that the dye‐entrapped nanocapsules degraded remarkably. These results highlighted the great potential of encapsulation for dye removal in economical and practical applications. CONCLUSION: Encapsulation was confirmed to be an economical and practical technique for effectively eliminating CR from aqueous solutions. Under UV light irradiation, the dye molecules entrapped within alginate nanocapsules displayed photodegradation. © 2024 Society of Chemical Industry (SCI). [ABSTRACT FROM AUTHOR]

BACKGROUND: Conventional pesticide formulations are often inefficient because of low biological uptake after spraying. Controlled release nanopesticides can release pesticides precisely in response to specific stimuli, thereby killing pests and pathogens using the least effective concentration. This study aims to develop nanocapsule‐based photo‐decomposable nanopesticides for efficient pesticide control. RESULTS: The target nanopesticides were successfully fabricated using layer‐by‐layer assembly of the negative azobenzene‐grafted hyaluronic acid (azo‐HA) and positive polydimethyldiallylammonium chloride (polyDADMAC), confirmed by UV‐visible, dynamic light scattering, Zeta potential and transmission electron microscopy measurements. The particle size and Zeta potential of the fabricated nanocapsules were 220 nm and +46.1 mV, respectively, and the nanocapsules were found to remain stable for up to 30 days. The optimized drug loading and encapsulation ratio of imidacloprid (IMI) in IMI/azo‐HA@polyDADMAC were 21.5% and 91.3%, respectively. Cumulative release of IMI from the nanopesticides increased from ~50% to ~95% upon UV light irradiation (365 nm). The half lethal concentration (LC50) value of the nanopesticides toward Aphis craccivora Koch decreased from 2.22 to 0.55 mg L−1 upon UV light irradiation. CONCLUSION: The trans to cis transformation of the azo group in HA decomposed IMI/azo‐HA@polyDADMAC nanopesticides upon UV irradiation, thus facilitating the release of IMI, resulting in a decrease in the concentration of pesticides required for efficient pesticide control. Our work demonstrated the great potential of light‐responsive nanocapsules as a controlled release nanocarrier for efficient and eco‐friendly pesticide control in sustainable agriculture. © 2024 Society of Chemical Industry. [ABSTRACT FROM AUTHOR]

Understanding the transport of nanoparticles from and within hydrogels is a key issue for the design of nanocomposite hydrogels for drug delivery systems and tissue engineering. To investigate the translocation of nanocarriers from and within hydrogel networks triggered by changes of temperature, ultrasmall (8 nm) and small (80 nm) silica nanocapsules are embedded in temperature‐responsive hydrogels and non‐responsive hydrogels. The ultrasmall silica nanocapsules are released from temperature‐responsive hydrogels to water or transported to other hydrogels upon direct activation by heating or indirect activation by Joule heating; while, they are not released from non‐responsive hydrogel. Programmable transport of nanocarriers from and in hydrogels provides insights for the development of complex biomedical devices and soft robotics. [ABSTRACT FROM AUTHOR]

Despite the recent developments in hydrochromic materials, visual detection of water level in plastic materials without sacrificing mechanical properties remains a meaningful yet challenging topic. Currently, to optimize the sensitivity, hydrochromic agents are usually incorporated into hygroscopic matrixes to form bulk solids, which have restricted compatibility for the direct application inside other polymer materials. In this study, this challenge is tackled by nanoscale incorporation of hydrochromic agent into a hygroscopic polymer by miniemulsion polymerization. The obtained hydrochromic nanocapsule has an average diameter ≈110 nm, shows reversible hydrochromic property after 10 cycles, and can offer the first directly eye‐readable signal about the real time in situ water level in plastic materials with a water level below 4 wt.%, while achieving a 214% enhancement of the toughness at the same time. Comprehensive researches by investigating the composition and viscoelastic transition of the nanocapsules has shed light on the mechanisms concerning hydrochromic sensitivity and toughening effect. This simple methodology not only offers a new route for the nanoscale incorporation and application of different hydrochromic materials, but also inspires the development of smart nanoparticles with other stimuli‐responsive functionalities. All these aspects should render this work interesting for both scientific researches and engineering practices. [ABSTRACT FROM AUTHOR]

Nanocapsules provide selective delivery and increase the bioavailability of bioactive compounds. In this study, we examined the anticancer and immunomodulatory potential of Fridericia chica (crajiru) extract encapsulated in nanocapsules targeting myeloid leukemias. Nanocapsules containing crajiru (nanocapsules-CRJ) were prepared via interfacial polymer deposition and solvent displacement. Size and polydispersity were measured by dynamic light scattering. Biological assays were performed on leukemia cell lines HL60 and K562 and on non-cancerous Vero cells and human PBMC. The anticancer activity was evaluated using cytotoxicity and clonogenic assays, while the immunomodulatory activity was evaluated by measuring the levels of pro- and anti-inflammatory cytokines in PBMC supernatants treated with concentrations of nanocapsules-CRJ. Nanocapsules-CRJ exhibited significant cytotoxic activity against HL60 and K562 cells at concentrations ranging from 0.75 to 50 μg/mL, with the greatest reductions in cell viability observed at 50 μg/mL (p < 0.001 for HL60; p < 0.01 for K562), while not affecting non-cancerous Vero cells and human PBMCs. At concentrations of 25 μg/mL and 50 μg/mL, nanocapsules-CRJ reduced the formation of HL60 and K562 colonies by more than 90% (p < 0.0001). Additionally, at a concentration of 12 μg/mL, nanocapsules-CRJ induced the production of the cytokines IL-6 (p = 0.0002), IL-10 (p = 0.0005), IL-12 (p = 0.001), and TNF-α (p = 0.005), indicating their immunomodulatory potential. These findings suggest that nanocapsules-CRJ hold promise as a potential therapeutic agent with both cytotoxic and immunomodulatory properties. [ABSTRACT FROM AUTHOR]

Lactoferrin (Lf), a multifunctional protein found abundantly in secretions, including tears, plays a crucial role in ocular health through its antimicrobial, immunoregulatory, anti-inflammatory, and antioxidant activities. Advanced delivery systems are desirable to fully leverage its therapeutic potential in treating ocular diseases. The process of Lf quantification for diagnostic purposes underscores the importance of developing reliable, cost-effective detection methods, ranging from conventional techniques to advanced nano-based sensors. Despite the ease and non-invasiveness of topical administration for ocular surface diseases, challenges such as rapid drug elimination necessitate innovations, such as Lf-loaded contact lenses and biodegradable polymeric nanocapsules, to enhance drug stability and bioavailability. Furthermore, overcoming ocular barriers for the treatment of posterior segment disease calls for nano-formulations. The scope of this review is to underline the advancements in nanotechnology-based Lf delivery methods, emphasizing the pivotal role of multidisciplinary approaches and cross-field strategies in improving ocular drug delivery and achieving better therapeutic outcomes for a wide spectrum of eye conditions. [ABSTRACT FROM AUTHOR]

Oil-core nanocapsules (NCs, also known as nanoemulsions) are of great interest due to their application as efficient carriers of various lipophilic bioactives, such as drugs. Here, we reported for the first time the preparation and characterization of NCs consisting of chondroitin sulfate (CS)-based shells and liquid oil cores. For this purpose, two amphiphilic CS derivatives (AmCSs) were obtained by grafting the polysaccharide chain with octadecyl or oleyl groups. AmCS-based NCs were prepared by an ultrasound-assisted emulsification of an oil phase consisting of a mixture of triglyceride oil and vitamin E in a dispersion of AmCSs. Dynamic light scattering and cryo-transmission electron microscopy showed that the as-prepared core–shell NCs have typical diameters in the range of 30–250 nm and spherical morphology. Since CS is a strong polyanion, these particles have a very low surface potential, which promotes their stabilization. The cytotoxicity of the CS derivatives and CS-based NCs and their impact on cell proliferation were analyzed using human keratinocytes (HaCaTs) and primary human skin fibroblasts (HSFs). In vitro studies showed that AmCSs dispersed in an aqueous medium, exhibiting mild cytotoxicity against HaCaTs, while for HSFs, the harmful effect was observed only for the CS derivative with octadecyl side groups. However, the nanocapsules coated with AmCSs, especially those filled with vitamin E, show high biocompatibility with human skin cells. Due to their stability under physiological conditions, the high encapsulation efficiency of their hydrophobic compounds, and biocompatibility, AmCS-based NCs are promising carriers for the topical delivery of lipophilic bioactive compounds. [ABSTRACT FROM AUTHOR]

Lemon essential oil (LEOs) is used as a bioactive compound with unique health properties as a medicine or dietary supplement. Nevertheless, essential oils are chemical compounds sensitive to light, oxidation, and thermal processes. Therefore, encapsulation technique can be a good way to protect them from degradation and evaporation. In current study, biopolymeric nanocapsules containing lemon essential oils (LEOs) were prepared by the emulsion method. The nanocapsules were characterized by their particle size and Encapsulation efficiency (%) ranged from 339.3 to 553.3 nm and 68.09% to 85.43%, respectively. Long-term storage (30 days) under different temperatures (4 °C, 25 °C, and 40 °C) conditions showed that nanocapsules stored at 4 °C were more stable than samples stored at higher temperatures. DPPH and ABTS free radical scavenging activity were measured to evaluate the values of antioxidant activity of LEOs and nanocapsules. The free LEO and nanocapsules were investigated for its antibacterial activity against common Gram-positive and Gram-negative pathogenic microorganisms (Staphylococcus aureus and Escherichia coli) using disk diffusion followed by the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC). Our results indicated that the encapsulated LEOs had a significant antioxidant and antibacterial activities, as compared to the free LEO. The LEOs nanocapsules in CS and Hicap can be suggested as an important natural alternative with suitable stability, antioxidant, and antibacterial properties to overcome the challenges associated with the direct application of these bioactive compounds in food. [ABSTRACT FROM AUTHOR]

Chitosan nanocapsules containing polyunsaturated fatty acid (PUFA) concentrates from tuna oil, with EPA + DHA contents around 57% (w/w), were developed by emulsification process, using different chitosan concentration (1.0%, 1.5%, 2.0%, w/v) and stirring speed (10,000, 15,000, 20,000 rpm). The effects of these parameters on particle size and zeta potential were evaluated. The physical and oxidative stabilities were used to measure the product quality during storage. Chitosan concentration, stirring speed and its interaction significantly affected (p < 0.05) the particle size. In addition, chitosan concentration significantly affected (p < 0.05) the zeta potential of nanocapsules emulsion. Based on the results of physical and oxidative stabilities, the nanocapsules were stable for 30 days under refrigeration temperature (7 °C), and with 1.5–2% chitosan resulted in improved protection against oil oxidation. The nanocapsules produced with 2% chitosan and 10,000 rpm showed the lowest variations of polydispersity index and nanocapsules size after 30 days of storage (221.8 ± 3.0 nm). These conditions can be considered the most suitable to produce nanocapsules of PUFA concentrates from tuna oil using chitosan as wall material. These nanocapsules showed physical characteristics and oxidative stability, which could enable their application in the food industry, representing an important source of EPA and DHA fatty acids. [ABSTRACT FROM AUTHOR]

Lipids have tremendously transformed the biomedical field, especially in the last few decades. Nanosystems, especially Lipid nanocapsules (LNCs), have emerged as the most demanding nanovehicle systems for delivering drugs, genes, and other diagnostic agents. Unique attributes and characteristic features such as higher encapsulation efficiency, stealth effect, ability to solubilize a wide range of drugs, capability to inhibit P-gp efflux pumps, and higher stability play a vital role in engaging this nanosystem. LNCs are a lipid-based nano-drug delivery method that combines the most significant traits of liposomes with polymeric nanoparticles. Structurally, LNCs have an oily core consisting of medium and long triglycerides and an aqueous phase encased in an amphiphilic shell. This manuscript crosstalks LNCs for various biomedical applications. A detailed elaboration of the structural composition, methods of preparation, and quality control aspects has also been attained, with particular emphasis on application approaches, ongoing challenges, and their possible resolution. The manuscript also expounds the preclinical data and discusses the patents atlas of LNCs to assist biomedical scientists working in this area and foster additional research. [ABSTRACT FROM AUTHOR]

In recent years, the development of nanomaterials with biocidal properties has received considerable attention due to their potential applications in various industries, including food, medicine, and cultural heritage preservation. The growing demand for coatings with antibacterial properties has sparked interest from industrial sectors in exploring the incorporation of biocides into these materials. Coatings are prone to microbial growth, which can cause damage such as cracking, discoloration, and staining. To combat these problems, the integration of biocides into coatings is a crucial strategy. Biocide-embedded nanomaterials offer numerous advantages, including high efficiency in small quantities, ease of application, good chemical stability, low toxicity, and non-bioaccumulation. Encapsulated nanobiocides are particularly attractive to the agro-industry, because they can be less toxic than traditional biocides while still effectively controlling microbial contamination. To fully exploit the benefits of nanobiocides, future research should focus on optimizing their synthesis, formulation, and delivery methods. The purpose of this review is to summarize the current status of biocide nanomaterials, discuss potential future research directions, and highlight research methods, the development of new forms of nanomaterials, and studies of their physico-chemical properties. Biocide nanocapsules of DCOIT (4,5-Dichloro-2-octyl-2H-isothiazol-3-one) are chosen as an example to illustrate the research pathways. [ABSTRACT FROM AUTHOR]

This study prepared a nanocapsule (NPs) from chitosan (CS) and sodium alginate (ALG) and used them to enhance the stability of blueberry anthocyanins (BA) The optimal NPs was obtained at pH value of 3.25, BA concentration of 0.5 mg/mL and mixing ratio of CS to ALG of 1:1 (W/W). Further, the formation of composite NPs was confirmed by a series of characterization methods. The CS-BA-ALG NPs appeared spherical, smooth, and evenly distributed when observed under an optical microscope and transmission Electron Microscope. The X-ray Diffractometer and Fourier Transform Infrared spectroscopy data proved that electrostatic interaction and hydrogen bonding are dominant forces to form NPs. Thermogravimetric analysis and differential scanning calorimetry results demonstrated that the CS-BA-ALG NPs system significantly improved the thermal stability of anthocyanins. In addition, it was also proved that CS-BA-ALG NPs showed high antioxidant capacity and protection capacity.

Abstract Nanocapsules enable multicomponent encapsulation of therapeutic cargoes with high encapsulation content and efficiency, which is vital for cancer immunotherapy. In the past, chemical crosslinking is used to synthesize nanocapsules, which can impede the regulatory approval process. Therefore, a new class of protein nanocapsules is developed by eliminating the need for chemical crosslinking by utilizing protein denaturation through a process that is referred to as “baking at the droplet interface”. Such protein nanocapsules with antigens incorporated in the shell and a combination of encapsulated drugs showed an enhancement in the immune response of cells.

Neurological disorders are the diseases associated with the central and peripheral nervous system. They are among the most serious and prevalent diseases nowadays. However, most of the pharmacological agents used to treat neurological disorders demonstrate severe toxicities and side effects, along with failure to achieve the desired outcomes due to their inability to cross the blood-brain barrier (BBB). Therefore, efforts have been made to develop potential drug carriers that can enhance the penetration of various therapeutic agents across the BBB. Due to the remarkable selectivity of nanoparticles and their ability to penetrate the BBB, they have attracted enormous interest as a viable solution to overcome these challenges. Polymeric nanoparticles used as drug delivery systems, in particular, demonstrated multiple advantages over traditional drug delivery systems in the treatment of neurological and psychological disorders due to several beneficial properties. This minireview article discusses the current literature on the use of chitosan nanoparticles in particular as promising carriers for delivering therapeutic agents to the brain for the treatment of different neurological diseases. The article emphasizes the advantages of using chitosan over other natural and synthetic polymers, and illustrates the methods of preparation of chitosan nanoparticles, in addition to the characterization of chitosan-based nanoparticles. The article also discusses the specific application of chitosan-based nanoparticles for brain targeting with the aim of the treatment of neurological disorders. Furthermore, challenges and future prospects were also discussed.

Highlights: The formation of peptide nanocapsules is facilitated by a gradient interface, where the differential solvent concentration drives the peptides to preferentially localize and assemble. The peptide nanocapsules, characterized by their hollow structures, demonstrated potential as carriers for targeted drug delivery. [ABSTRACT FROM AUTHOR]

Rheumatoid arthritis (RA) is a chronic autoimmune disease of yet undetermined etiology that is accompanied by significant oxidative stress, inflammatory responses, and damage to joint tissues. In this study, we designed chondroitin sulfate (CS)-modified tragacanth gum–gelatin composite nanocapsules (CS-Cur-TGNCs) loaded with curcumin nanocrystals (Cur-NCs), which rely on the ability of CS to target CD44 to accumulate drugs in inflamed joints. Cur was encapsulated in the form of nanocrystals into tragacanth gum–gelatin composite nanocapsules (TGNCs) by using an inborn microcrystallization method, which produced CS-Cur-TGNCs with a particle size of approximately 80 ± 11.54 nm and a drug loading capacity of 54.18 ± 5.17%. In an in vitro drug release assay, CS-Cur-TGNCs showed MMP-2-responsive properties. During the treatment of RA, CS-Cur-TGNCs significantly inhibited oxidative stress, promoted the polarization of M2-type macrophages to M1-type macrophages, and decreased the expression of inflammatory factors (TNF-α, IL-1β, and IL-6). In addition, it also exerted excellent anti-inflammatory effects, and significantly alleviated the swelling of joints during the treatment of gouty arthritis (GA). Therefore, CS-Cur-TGNCs, as a novel drug delivery system, could lead to new ideas for clinical therapeutic regimens for RA and GA. [ABSTRACT FROM AUTHOR]

This study evaluated the effects of topically applied hydrogels (HG) containing nanoencapsulated indol-3-carbinol (I3C) and its free form in a rat model of skin wounds. Formulations were topically applied twice a day for five days to the wounds. On days 1, 3, and 6, the wound area was measured to verify the % of regression. On the sixth day, the animals were euthanized for the analysis of the inflammatory and oxidative profile in wounds. The nanocapsules (NC) exhibited physicochemical characteristics compatible with this kind of suspension. After five hours of exposure to ultraviolet C, more than 78% of I3C content in the suspensions was still observed. The NC-I3C did not modify the physicochemical characteristics of HG when compared to the HG base. In the in vivo study, an increase in the size of the wound was observed on the 3rd experimental day, which was lower in the treated groups (mainly in HG-NC-I3C) compared to the control. On the 6th day, HG-I3C, HG-NC-B, and HG-NC-I3C showed lower regression of the wound compared to the control. Additionally, HG-NC-I3C exhibited an anti-inflammatory effect (as observed by decreased levels of interleukin-1B and myeloperoxidase), reduced oxidative damage (by decreased reactive species, lipid peroxidation, and protein carbonylation levels), and increased antioxidant defense (by improved catalase activity and vitamin C levels) compared to the control. The current study showed more satisfactory results in the HG-NC-I3C group than in the free form of I3C in decreasing acute inflammation and oxidative damage in wounds. HIGHLIGHTS: I3C nanocapsules exhibited characteristics compatible with this kind of suspension; On 3rd day, I3C nanocapsules prevented the increase of wound area; I3C nanocapsules decreased oxidative damage in wound tissue; Inflammatory proteins were decreased in I3C nanocapsules treated group; [ABSTRACT FROM AUTHOR]

Featured Application: In this study, taking advantage of their bioactive properties, rosehip nanocapsules were applied to pork marinating systems to obtain marinated products with added value and improved texture. An evaluation of the changes in collagen is a good reference associated with these enhancements. The objective of this study was to prepare zein–gum Arabic nanocapsules with rosehip oil (NC-RH), apply them to pork tenderloin, and analyze the changes in collagen structure under different conditions (pH 6.5 and 4.0) and temperatures (25 °C and 4 °C). NC-RHs were prepared using the nanoprecipitation method. Nanocapsules had a particle size of 423 ± 4.1 nm, a polydispersity index of 0.125 ± 3.1, a zeta potential value of −20.1 ± 0.41 mV, an encapsulation efficiency of 75.84 ± 3.1%, and backscattering (ΔBS = 10%); the antioxidant capacity of DPPH was 1052 ± 4.2 µM Eq Trolox and the radical scavenging capacity was 84 ± 0.4%. The dispersions exhibited Newtonian behavior at 25 °C and 4 °C. Incorporating NC-RH into acid marination benefited the tenderness, water-holding capacity, and collagen swelling, and favored changes in myofibrillar proteins corroborated with histological tests. The conditions with the best changes in pork tenderloin were a pH of 4.0 at 4 °C with an NC-RH-administered 11.47 ± 2.2% collagen area. Incorporating rosehip nanocapsules modifies collagen fibers and can be applied in pork marinades to increase the shelf life of a functional product. [ABSTRACT FROM AUTHOR]

In recent years, biopolymer-based nano-drug delivery systems with antioxidative properties have gained significant attention in the field of pharmaceutical research. These systems offer promising strategies for targeted and controlled drug delivery while also providing antioxidant effects that can mitigate oxidative stress-related diseases. Generally, the healthcare landscape is constantly evolving, necessitating the continual development of innovative therapeutic approaches and drug delivery systems (DDSs). DDSs play a pivotal role in enhancing treatment efficacy, minimizing adverse effects, and optimizing patient compliance. Among these, nanotechnology-driven delivery approaches have garnered significant attention due to their unique properties, such as improved solubility, controlled release, and targeted delivery. Nanomaterials, including nanoparticles, nanocapsules, nanotubes, etc., offer versatile platforms for drug delivery and tissue engineering applications. Additionally, biopolymer-based DDSs hold immense promise, leveraging natural or synthetic biopolymers to encapsulate drugs and enable targeted and controlled release. These systems offer numerous advantages, including biocompatibility, biodegradability, and low immunogenicity. The utilization of polysaccharides, polynucleotides, proteins, and polyesters as biopolymer matrices further enhances the versatility and applicability of DDSs. Moreover, substances with antioxidative properties have emerged as key players in combating oxidative stress-related diseases, offering protection against cellular damage and chronic illnesses. The development of biopolymer-based nanoformulations with antioxidative properties represents a burgeoning research area, with a substantial increase in publications in recent years. This review provides a comprehensive overview of the recent developments within this area over the past five years. It discusses various biopolymer materials, fabrication techniques, stabilizers, factors influencing degradation, and drug release. Additionally, it highlights emerging trends, challenges, and prospects in this rapidly evolving field. [ABSTRACT FROM AUTHOR]

Research into drug delivery and tissue engineering (TE) has made great strides in the current era because of its limitless potential to enhance human health. In the meantime, the advancement of nanotechnology offers chances to categorize, control, and arrange orderly arrangements of materials at the nanoscale ranking. Biomaterials with the nanoscale organization have been applied to TE as artificial matrices and controlled-release drug reservoirs. Drug delivery systems may be created with precise control over composition, morphology, size, and shape. Their surface characteristics might be changed to improve solubility, immune compatibility, and cellular absorption. Current drug delivery methods include drawbacks such as poor bioavailability, ineffective targeting, and possible cytotoxicity. Dendrimers, nanoparticles, nanocapsules, nanotubes, and nano gels are auspicious and adaptable nano-scale medicine transportation methods. Small-molecule medications and numerous biomacromolecules can be delivered using them. Current TE scaffolds differ from earlier ones because they are based on something other than hydrolytically degradable macroporous materials. Methods highlight nanoscale topography resembling the natural extracellular matrix (ECM) to influence cell activities and tissue creation. Researchers were inspired to create nanofibrous congeners using electrospinning or self-assembly after realizing that the natural ECM is a multifunctional nanocomposite. It has been demonstrated that nanocrystal-containing nanocomposites stimulate active bone formation. TE and drug delivery are areas that are closely connected. The objective of TE is to achieve controlled distribution of mammalian cells, which can be seen as a specific example of medication delivery. Consequently, the effectiveness of TE will be improved by the controlled release of therapeutic elements. Both the medication delivery systems and the scaffolds used in TE must be biocompatible and biodegradable from a material standpoint. By creating biomaterials with regulated properties, the biotic capabilities of encapsulated pharmaceuticals and cells may be significantly improved. The latest advancements in using nanostructured ingredients for TE and medication delivery are summarised in this study. [ABSTRACT FROM AUTHOR]

Granzyme B (GrB)-based immunotherapy is of interest for cancer treatment. However, insufficient cellular uptake and a lack of targeting remain challenges to make use of GrB for solid tumour therapy. As GrB induced cell death requires the help of perforin (PFN), we designed a system (nGPM) for the co-delivery of GrB and PFN. Therefore, GrB and PFN were loaded in a porous polymeric nanocapsule rich in acetylcholine analogues and matrix metalloproteinase-2 (MMP-2) responsive peptides. The neutrally charged nGPM nanocapsules showed as long circulating time and accumulated at the tumour sites. Once in the tumour the outside shell of nanocapsules became degraded by overexpressed MMP-2 proteases, resulting in the release of GrB and PFN. We found that the PFN complex formed small pores on the surface of tumour cells which allow GrB to enter the cytoplasm of tumour cells inducing cell apoptosis and tumour suppression significantly. [Display omitted] [ABSTRACT FROM AUTHOR]

Vaccines represent one of the most powerful and cost-effective innovations for controlling a wide range of infectious diseases caused by various viruses and bacteria. Unlike mRNA and DNA-based vaccines, subunit vaccines carry no risk of insertional mutagenesis and can be lyophilized for convenient transportation and long-term storage. However, existing adjuvants are often associated with toxic effect and reactogenicity, necessitating expanding the repertoire of adjuvants with better biocompatibility, for instance, designing self-adjuvating polymeric carriers. We herein report a novel subunit vaccine delivery platform constructed via in situ free radical polymerization of C7A (2-(Hexamethyleneimino) ethyl methacrylate) and acrylamide around the surface of individual protein antigens. Using ovalbumin (OVA) as a model antigen, we observed substantial increases in both diameter (∼70 nm) and surface potential (−1.18 mV) following encapsulation, referred to as n(OVA)C7A. C7A's ultra pH sensitivity with a transition pH around 6.9 allows for rapid protonation in acidic environments. This property facilitates crucial processes such as endosomal escape and major histocompatibility complex (MHC)-I-mediated antigen presentation, culminating in the substantial CD8+ T cell activation. Additionally, compared to OVA nanocapsules without the C7A components and native OVA without modifications, we observed heightened B cell activation within the germinal center, along with remarkable increases in serum antibody and cytokine production. It's important to note that mounting evidence suggests that adjuvant effects, particularly its targeted stimulation of type I interferons (IFNs), can contribute to advantageous adaptive immune responses. Beyond its exceptional potency, the nanovaccine also demonstrated robust formation of immune memory and exhibited a favorable biosafety profile. These findings collectively underscore the promising potential of our nanovaccine in the realm of immunotherapy and vaccine development. Schematic illustration of the preparation process of bioresponsive nanovaccine (n(OVA)C7A) and the induction of adaptive immune responses. Firstly, pH-responsive 2-(hexamethyleneimino) ethyl methacrylate (C7A-MA) and acrylamide (AAm), along with the biodegradable crosslinker N,N′ -Bis(acryloyl) cystamine, were initially enriched on the surface of OVA through non-covalent bonding. Secondly, after subcutaneous injection of mice at the hind footpad, the developed nanovaccine n(OVA)C7A rapidly were accumulated in lymph nodes and promoted the uptake and maturation of lymph node-resident DCs, triggering a series of adaptive humoral and cellular immune responses. [Display omitted] • Vaccine carriers with dispersed C7A groups form polymer networks encompassing the antigen. • C7A's ultra pH sensitivity facilitates endosomal escape and MHC-I-mediated antigen presentation. • Self-adjuvanting polymeric nanovaccines (n(OVA)C7A) foster substantial cytotoxic T cell activation and IFNs production. • This nanoplatform has the potential to deliver a variety of protein antigens against viral infections and cancer. [ABSTRACT FROM AUTHOR]

Sepsis represents a complex clinical syndrome that results from a harmful host response to infection. The infections most associated with sepsis are pneumonia, intra-abdominal infection, and urinary tract infection. Tea tree oil (TTO) has shown high antibacterial activity; however, it exhibits low aqueous solubility and high volatility, which have motivated its nanoencapsulation. In this study, the performance of nanoemulsions (NE) and nanocapsules (NC) loaded with TTO was compared. These systems were prepared by spontaneous emulsification and nanoprecipitation methods, respectively. Poly-ε-caprolactone or Eudragit® RS100 were tested as polymers for NCs whereas Tween® 80 or Pluronic® F68 as surfactants in NE preparation. Pluronic® F68 and Eudragit® RS100 resulted in more homogeneous and stable nanoparticles. In accelerated stability studies at 4 and 25 °C, both colloidal suspensions (NC and NE) were kinetically stable. NCs showed to be more stable to photodegradation and less cytotoxic than NEs. After sepsis induction by the cecal ligation and puncture (CLP) model, both NE and NC reduced neutrophil infiltration into peritoneal lavage (PL) and kidneys. Moreover, the systems increased group thiols in the kidney and lung tissue and reduced bacterial growth in PL. Taken together, both systems showed to be effective against injury induced by sepsis; however, NCs should be prioritized due to advantages in terms of cytotoxicity and physicochemical stability. [ABSTRACT FROM AUTHOR]

Gallic acid–Antarctic krill peptides (GA-AKP) nanocapsules (GA-AKP-Ns) were prepared using a dual delivery system with complex emulsion as the technical method, a high-pressure microjet as the technical means, polylactic acid–hydroxyacetic acid (PLGA) as the drug delivery vehicle, and GA-AKP as the raw material for delivery. This study aimed to investigate the effects of microjet treatment and the concentration of PLGA on the physicochemical properties and stability of the emulsion. Under optimal conditions, the physicochemical properties and hypoglycemic function of nano-microcapsules prepared after lyophilization by the solvent evaporation method were analyzed. Through the microjet treatment, the particle size of the emulsion was reduced, the stability of the emulsion was improved, and the encapsulation rate of GA-AKP was increased. The PLGA at low concentrations decreased the particle size of the emulsion, while PLGA at high concentrations enhanced the encapsulation efficiency of the emulsion. Additionally, favorable results were obtained for emulsion preparation through high-pressure microjet treatment. After three treatment cycles with a PLGA concentration of 20 mg/mL and a microjet pressure of 150 MPa (manometric pressure), the emulsion displayed the smallest particle size (285.1 ± 3.0 nm), the highest encapsulation rates of GA (71.5%) and AKP (85.2%), and optimal physical stability. GA-AKP was uniformly embedded in capsules, which can be slowly released in in vitro environments, and effectively inhibited α-amylase, α-glucosidase, and DPP-IV at different storage temperatures. This study demonstrated that PLGA as a carrier combined with microjet technology can produce excellent microcapsules, especially nano-microcapsules, and these microcapsules effectively improve the bioavailability and effectiveness of bioactive ingredients. [ABSTRACT FROM AUTHOR]

The synthesis of active films with natural antimicrobials from renewable sources offers an alternative to conventional non-biodegradable packaging and synthetic additives. This study aimed to develop cassava starch films with antimicrobial activity by incorporating either free carvacrol or chia mucilage nanocapsules loaded with carvacrol (CMNC) and assess their impact on the physical, mechanical, and barrier properties of the films, as well as their efficacy against foodborne pathogens. The addition of free carvacrol led to a reduction in mechanical properties due to its hydrophobic nature and limited interaction with the polymeric matrix. Conversely, CMNC enhanced elongation at break and reduced light transmission, with a more uniform distribution in the polymeric matrix. Films containing 8% carvacrol exhibited inhibitory effects against Salmonella and Listeria monocytogenes, further potentiated when encapsulated in chia mucilage nanocapsules. These findings suggest that such films hold promise as active packaging materials to inhibit bacterial growth, ensuring food safety and extending shelf life. [ABSTRACT FROM AUTHOR]

In this paper, polyamine-functionalized carbon dots (CDs) were synthesized by means of low temperature (<100°C) carbonization of citric acid at the presence of polyethylenimine (PEI), resulting spherical calcium carbonate micro-particles from inverse micro-emulsion system. Nanoscaled spherical silicas were prepared by Stöber method via deposition on the surface of micron calcium carbonate. Scanning- and transmission-electron microscopic analysis confirmed a micro-/nano-complex structure, enabling the composite material coating possessed coarser surface similar to those of 'lotus leaf'. After modification with 1 H, 1 H, 2 H, 2 H-perfluorodecanethiol, both good super hydrophobicity and good fluorescent performance were confirmed by the water contact angle of 154.1°±1.5°, their surface-free energy, and fluorescence quantum yield of 14.1%, which provides an inexpensive and easy way to fabricate superhydrophobic material with fluorescence characteristics and promotes high value application of inorganic materials. [ABSTRACT FROM AUTHOR]

Lidocaine is the most commonly used local anesthetic worldwide, known for its rapid onset and moderate duration of anesthesia. However, it is short-lived and does not effectively promote effective topical anesthesia in the oral cavity when used alone. Our aim was to investigate whether an approximate 50% encapsulation of lidocaine in poly(ε-caprolactone) nanocapsules (LDC-Nano) would be able to increase its permeation and analgesic efficacy and reduce cytotoxicity. In this study, we characterized LDC-Nano and conducted MTT tests with HaCaT cells to assess their in vitro cytotoxicity. Additionally, in vitro permeation assays across the pig esophageal epithelium and the anesthetic efficacy of the hind paw incision model in rats were performed. Plain lidocaine (LDC) was compared with LDC-Nano and lidocaine hydrochloride plus epinephrine (LDC-Epi). The physicochemical characteristics of LDC-Nano were satisfactory (pH: 8.1 ± 0.21; polydispersity index: 0.08 ± 0.01; mean diameter (nm): 557.8 ± 22.7; and encapsulation efficiency (%): 51.8 ± 1.87) and remained stable for up to 4 months. LDC-Nano presented similar in vitro cytotoxicity to LDC but was higher than LDC-Epi (LD50: LDC = 0.48%; LDC-Nano = 0.47%; and LDC-Epi = 0.58%; p < 0.0001). Encapsulation increased the permeability coefficient about 6.6 times and about 7.5 the steady-state flux of lidocaine across the mucosal epithelium. Both encapsulation and epinephrine improved anesthesia duration, with epinephrine demonstrating superior efficacy (100% of animals were anesthetized up to 100, 30, and 20 min when LDC-Epi, LDC-nano, and LDC were used, respectively). Although LDC-Epi demonstrated superior in vivo anesthetic efficacy, the in vitro permeation and cytotoxicity of LDC-Nano indicate promising avenues for future research, particularly in exploring its potential application as a topical anesthetic in the oral cavity. [ABSTRACT FROM AUTHOR]